These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22829968)

  • 1. Clonal evolution in UKE-1 cell line leading to an increase in JAK2 copy number.
    Buors C; Douet-Guilbert N; Morel F; Lecucq L; Cassinat B; Ugo V
    Blood Cancer J; 2012 Apr; 2(4):e66. PubMed ID: 22829968
    [No Abstract]   [Full Text] [Related]  

  • 2. Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells.
    Fiskus W; Verstovsek S; Manshouri T; Rao R; Balusu R; Venkannagari S; Rao NN; Ha K; Smith JE; Hembruff SL; Abhyankar S; McGuirk J; Bhalla KN
    Clin Cancer Res; 2011 Dec; 17(23):7347-58. PubMed ID: 21976548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in urinary kallikrein excretion following hemodialysis.
    Girolami JP; Bascands JL; Vega Vidalle C; Pecher C; Moatti JP; Adam A; Suc JM
    Nephron; 1991; 59(1):51-6. PubMed ID: 1944748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
    Quentmeier H; MacLeod RA; Zaborski M; Drexler HG
    Leukemia; 2006 Mar; 20(3):471-6. PubMed ID: 16408098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary kallikrein excretion following chronic sinoaortic denervation in conscious dogs.
    Valet P; Bascands JL; Pecher C; Cabos G; Moatti JP; Montastruc JL; Girolami JP
    Clin Exp Hypertens A; 1989; 11(2):215-31. PubMed ID: 2650929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary kallikrein excretion in non-insulin-dependent diabetes mellitus.
    Tsai TJ; Tai TY; Chen YM; Chen WY; Yen TS
    J Formos Med Assoc; 1992 Jul; 91(7):725-8. PubMed ID: 1360304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary kallikrein excretion in chronic renal disease with respect to salt intake and renal reserve.
    Tsai TJ; Su CJ; Chen YM; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Jun; 90(6):525-30. PubMed ID: 1680995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal kallikrein excretion as a distal nephrotoxicity marker during cadmium exposure in rats.
    Girolami JP; Bascands JL; Pécher C; Cabos G; Moatti JP; Mercier JF; Haguenoer JM; Manuel Y
    Toxicology; 1989 Apr; 55(1-2):117-29. PubMed ID: 2652377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo.
    Verger E; Soret-Dulphy J; Maslah N; Roy L; Rey J; Ghrieb Z; Kralovics R; Gisslinger H; Grohmann-Izay B; Klade C; Chomienne C; Giraudier S; Cassinat B; Kiladjian JJ
    Blood Cancer J; 2018 Oct; 8(10):94. PubMed ID: 30287855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Chen M; Pockaj B; Andreozzi M; Barrett MT; Krishna S; Eaton S; Niu R; Anderson KS
    Clin Breast Cancer; 2018 Oct; 18(5):e1205-e1215. PubMed ID: 29933930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.
    Fleischman AG; Aichberger KJ; Luty SB; Bumm TG; Petersen CL; Doratotaj S; Vasudevan KB; LaTocha DH; Yang F; Press RD; Loriaux MM; Pahl HL; Silver RT; Agarwal A; O'Hare T; Druker BJ; Bagby GC; Deininger MW
    Blood; 2011 Dec; 118(24):6392-8. PubMed ID: 21860020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia.
    Kapralova K; Horvathova M; Pecquet C; Fialova Kucerova J; Pospisilova D; Leroy E; Kralova B; Milosevic Feenstra JD; Schischlik F; Kralovics R; Constantinescu SN; Divoky V
    Blood; 2016 Sep; 128(10):1418-23. PubMed ID: 27389715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.
    Milosevic Feenstra JD; Nivarthi H; Gisslinger H; Leroy E; Rumi E; Chachoua I; Bagienski K; Kubesova B; Pietra D; Gisslinger B; Milanesi C; Jäger R; Chen D; Berg T; Schalling M; Schuster M; Bock C; Constantinescu SN; Cazzola M; Kralovics R
    Blood; 2016 Jan; 127(3):325-32. PubMed ID: 26423830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F.
    Schaub FX; Jäger R; Looser R; Hao-Shen H; Hermouet S; Girodon F; Tichelli A; Gisslinger H; Kralovics R; Skoda RC
    Blood; 2009 Feb; 113(9):2022-7. PubMed ID: 19047681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Increased Copy Number is Associated with Emergence of Dominant Clones of the Irish Potato Famine Pathogen Phytophthora infestans.
    Knaus BJ; Tabima JF; Shakya SK; Judelson HS; Grünwald NJ
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer.
    Gao R; Davis A; McDonald TO; Sei E; Shi X; Wang Y; Tsai PC; Casasent A; Waters J; Zhang H; Meric-Bernstam F; Michor F; Navin NE
    Nat Genet; 2016 Oct; 48(10):1119-30. PubMed ID: 27526321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on reliability of commercially available hepatitis C virus antibody tests.
    Feucht HH; Zöllner B; Polywka S; Laufs R
    J Clin Microbiol; 1995 Mar; 33(3):620-4. PubMed ID: 7751366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors.
    Su Q; Ioannidis S; Chuaqui C; Almeida L; Alimzhanov M; Bebernitz G; Bell K; Block M; Howard T; Huang S; Huszar D; Read JA; Rivard Costa C; Shi J; Su M; Ye M; Zinda M
    J Med Chem; 2014 Jan; 57(1):144-58. PubMed ID: 24359159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of heterogeneous cell populations in the Ishikawa cell line during long-term culture: Proposal for an in vitro clonal evolution model of tumor cells.
    Kasai F; Hirayama N; Ozawa M; Iemura M; Kohara A
    Genomics; 2016 Jun; 107(6):259-66. PubMed ID: 27107655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of COP9, JAK2, HSP and NADH in ovarian carcinoma tissues after taxol-chemotherapy and their significance].
    Li HX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):528-32. PubMed ID: 19080518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.